Navigation Links
Fipronil and imidacloprid reduce honeybee mitochondrial activity
Date:8/6/2014

PENSACOLA, Fla. New research published in Environmental Toxicology and Chemistry addresses the effects of two broad-spectrum systemic insecticides, fipornil and imidacloprid, on honeybees. These insecticides are widely used in agriculture, and the authors conclude that fipronil and imidacloprid are inhibitors of mitochondrial bioenergetics, resulting in depleted cell energy. This action can explain the toxicity of these compounds for honeybees.

Scientists are urgently trying to determine the causes of colony collapse disorder and the alarming population declines of honeybees. The cross-pollination services they provide are required by approximately 80 percent of all flowering plants, and 1/3 of all agricultural food production directly depends on bee pollination. As a result, there has been a flurry of research on honeybee parasitic mite infestations, viral diseases, and the direct and indirect impacts of pesticides.

The effects of pyrazoles (e.g., fipronil) and neonicotinoids (e.g., imidacloprid) on the nervous system are fairly well documented. Daniel Nicodemo, professor of ecology and beekeeping at the Universidade Estadual Paulista in Dracena, Brazil, and lead author of the study states, "These insecticides affect the nervous system of pest and beneficial insects, often killing them. Sublethal effects related to insect behavior have been described in other studies; even a few nanograms of active ingredient disturbed the sense of taste, olfactory learning and motor activity of the bees." A key characteristic of colony collapse disorder is the incapacity of the honeybees to return to their hives, and these disruptions have a direct impact on that ability.

In this study, Nicodemo et al. looked at the effects of fipronil and imidacloprid on the bioenergetics functioning of mitochondria isolated from the heads and thoraces of Africanized honeybees. Mitochondria are the power plants of a cell, generating most of a cell's supply of adenosine triphosphate (ATP), used as a source of chemical energy.

Honeybee flight muscles are strongly dependent on high levels of oxygen consumption and energy metabolism. Mitochondrial oxidative phosphorylation drives ATP synthesis, which is required to contract the muscles during flight. "If something goes wrong, the energy production is impaired," explains Nicodemo. "Similar to a plane, honeybees require clean fuel in order to fly." Both fipronil and imidacloprid negatively affected the mitochondrial bioenergetics of the head and thorax of the honeybees. While at sublethal levels, insecticide damage may not be evident, even such low level exposure clearly contributes to the inability of a honeybee to forage and return to the hive, which could result in declining bee populations.


'/>"/>

Contact: Jennifer Lynch
jen.lynch@setac.org
850-469-1500 x109
Society of Environmental Toxicology and Chemistry
Source:Eurekalert

Related medicine news :

1. Production and Market of Imidacloprid in China
2. Community pharmacist intervention boosts drug adherence, reduces health-care costs
3. Diet change -- A solution to reduce water use?
4. 5 Tips for Back-to-School: What You Need to Know to Reduce Stress and Plan for a Healthy Transition from Nina Radcliff, MD
5. Eating resistant starch may help reduce red meat-related colorectal cancer risk
6. Algorithm reduces use of CT scans when diagnosing children with appendicitis
7. Cataract Surgery: New Technology for Reduced Dependence on Glasses
8. New Standing Desk Anti-fatigue Mats from Martinson-Nicholls Reduce Leg Fatigue and Discomfort Working at Standing and Sit-to-Stand Desks
9. Surgical safety program greatly reduces surgical site infections for heart operations
10. Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening
11. Seeing the same GP at every visit will reduce emergency department attendance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... ... , ... Are You Concerned About Mold In Your Home or Workplace? ... Companies in VA, MD and DC, recently completed its application for the new District ... in the district of Columbia is a good thing stated John Taylor, Owner of ...
(Date:12/2/2016)... ... December 02, 2016 , ... Lori G. Cohen and Sara ... speak at the American Conference Institute’s 21st Drug & Medical Device Litigation Conference ... Sponsor of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device & ...
(Date:12/2/2016)... Los Angeles, CA (PRWEB) , ... December 02, 2016 , ... For over twenty-four years, ... a lien basis to help personal injury victims find high quality medical care. When ... the Los Angeles area. Fast forward to present day and the now ten-page directory ...
(Date:12/2/2016)... ... December 02, 2016 , ... FlexiSpot, ... of its 60-day free trial program for all of the company’s desktop riser ... a truly hassle free experience. , FlexiSpot’s unique desktop risers use an advanced ...
(Date:12/2/2016)... New York, NY (PRWEB) , ... December 02, 2016 , ... ... Through an exclusive interview with Mediaplanet, Dr. Murthy explains how he was inspired to ... “Early on I learned that medicine is about more than making diagnoses and prescribing ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... -- Seno Medical Instruments, Inc., the company pioneering the development ... the process of diagnosing breast cancer, today announced that ... surveillance and clinical follow-up study at the 2016 ... from December 6-10, 2016 at the Henry B. Gonzalez ... . Seno Medical Instruments will present two ...
(Date:12/5/2016)... and TAIPEI, Taiwan , Dec. ... months of treatment ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) ... a significantly better safety and tolerability profile of ropeginterferon alfa-2b ... from PROUD-PV and the ongoing long-term follow-up trial CONTINUATION-PV to ... PharmaEssentia intends to present this data to the FDA ...
(Date:12/4/2016)... 3, 2016 Sickle cell disease (SCD) is ... blood cells that get stuck in veins and block ... failure, and complications leading to death. Each year, approximately ... and most of them lack access to comprehensive care ... long-term therapy for SCD, a pill called hydroxyurea approved ...
Breaking Medicine Technology: